CAS 1137-67-3 | 1H-Benzimidazole, 2-(3-pyridinyl)- | CAS Number 1137-67-3

200,000+ products from a single source!

sales@angenechem.com

Product Categories

Home > Imidazoles > 1137-67-3

1137-67-3 | 1H-Benzimidazole, 2-(3-pyridinyl)-

CAS No: 1137-67-3 Catalog No: AG0009DY MDL No:MFCD00022665

Product Description

Catalog Number:

AG0009DY

Chemical Name:

1H-Benzimidazole, 2-(3-pyridinyl)-

CAS Number:

1137-67-3

Molecular Formula:

C12H9N3

Molecular Weight:

195.2200

MDL Number:

MFCD00022665

IUPAC Name:

2-pyridin-3-yl-1H-benzimidazole

InChI:

InChI=1S/C12H9N3/c1-2-6-11-10(5-1)14-12(15-11)9-4-3-7-13-8-9/h1-8H,(H,14,15)

InChI Key:

BOUOQESVDURNSB-UHFFFAOYSA-N

SMILES:

c1ccc(cn1)c1nc2c([nH]1)cccc2

NSC Number:

62610

Properties

Complexity:

219

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

195.08g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

195.225g/mol

Monoisotopic Mass:

195.08g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

41.6A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

2.2

Literature

Title	Journal
Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.	Journal of medicinal chemistry 20120412
Selective fluorometric detection of pyrophosphate and stringent alarmone with copper(II)-2,6-bis(2-benzimidazolyl)pyridine complex.	Biosensors & bioelectronics 20111215
Optimizing sensitization processes in dinuclear luminescent lanthanide oligomers: selection of rigid aromatic spacers.	Journal of the American Chemical Society 20111012
Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones.	Scientia pharmaceutica 20110101
Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors.	Bioorganic & medicinal chemistry letters 20100715
2-(3-Pyridinio)benzimidazolium penta-chloridoanti-monate(III) monohydrate.	Acta crystallographica. Section E, Structure reports online 20090601
Poly[[2-(3-pyridinio)-1H,3H-benzimidazolium] [μ(4)-oxido-di-μ(3)-oxido-tetra-μ(2)-oxido-hexa-oxidotetra-molybdenum(VI)]].	Acta crystallographica. Section E, Structure reports online 20090501
catena-Poly[[bis-[μ-2-(3-pyrid-yl)-1H-benzimidazole]-κN:N;κN:N-disilver(I)]-μ-2,5-dicarboxy-benzene-1,4-dicarboxyl-ato-κO:O].	Acta crystallographica. Section E, Structure reports online 20080301
Influence of lipophilia and of the vehicle used in the transdermal absorption of novel benzimidazole compounds with possible anti-HIV activity.	Pharmaceutical development and technology 20080101
Microsphere-based protease assays and screening application for lethal factor and factor Xa.	Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Metal-mediated inhibition of Escherichia coli methionine aminopeptidase: structure-activity relationships and development of a novel scoring function for metal-ligand interactions.	Journal of medicinal chemistry 20060126
SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes.	Journal of the American Chemical Society 20040303